Stempoint Capital’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Sell
525,639
-94,127
-15% -$2.26M 2.58% 12
2025
Q4
$12.7M Sell
619,766
-93,697
-13% -$1.52M 2.17% 13
2025
Q3
$9.19M Buy
713,463
+26,924
+4% +$282K 1.84% 15
2025
Q2
$6.14M Buy
686,539
+445,713
+185% +$4.07M 1.97% 20
2025
Q1
$2.81M Sell
240,826
-109,747
-31% -$1.28M 0.9% 29
2024
Q4
$5.03M Buy
350,573
+167,655
+92% +$1.78M 1.26% 28
2024
Q3
$2.19M Buy
182,918
+39,408
+27% +$348K 0.66% 36
2024
Q2
$1.57M Buy
+143,510
New +$1.48M 0.46% 40

Other funds holding SRZN

Stempoint Capital's SRZN Position: Q1 2026 in Review

Stempoint Capital reduced its Surrozen (SRZN) stake by 15% in Q1 2026, selling an estimated $2.26M and leaving 525,639 shares worth $13.5M. The position accounts for 2.58% of the portfolio, ranked #12.

Stempoint Capital first reported a position in SRZN in Q2 2024 and has held it in 8 quarters since. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Stempoint Capital held 525,639 shares of Surrozen worth $13.5M as of Q1 2026.
  • Stempoint Capital sold 94,127 Surrozen shares in Q1 2026, an estimated $2.26M.
  • Surrozen made up 2.58% of Stempoint Capital's portfolio in Q1 2026, its #12 holding.
  • Stempoint Capital first reported a position in Surrozen in Q2 2024 and has held it in 8 quarters since.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.